| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/18/2002 | WO2001079273A3 Viruses comprising mutated ion channel protein |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001062920A3 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 07/18/2002 | WO2001060400B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 07/18/2002 | WO2001058461A9 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 07/18/2002 | WO2001052614A9 Selecting and producing t cell peptide epitopes |
| 07/18/2002 | WO2001051520A9 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2002 | WO2001051517A9 Candida hemolysin - like proteins and their uses |
| 07/18/2002 | WO2001037869A9 Vaccine compositions |
| 07/18/2002 | WO2001006991A9 Oil-in-water emulsion with improved stability |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |
| 07/18/2002 | US20020095027 Polypeptide for use in the diagnosis and treatment of viral diseases in animals |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094965 Purified and isolated polynucleotide molecules that encode the Chlamydia polypeptides designated glutamate binding protein which can be used in methods to prevent, treat, and diagnose Chlamydia pneumoniae; vaccines |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094576 Material and methods relating to a novel retrovirus |
| 07/18/2002 | US20020094552 Rickettsia felis outer membrane protein |
| 07/18/2002 | US20020094542 Drugs and methods for treating cancer |
| 07/18/2002 | US20020094534 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 07/18/2002 | US20020094524 Preventing preferential viral disease; obtain human, administer an antagonist of neurokinin receptors, monitor humans for reduced viral activity |
| 07/18/2002 | US20020094349 Administering an extract of Melothria indica Lou (perennial barbaceous vine) to the leukemia cells and prostate cancer cells; solvent extraction and chromatographic purification |
| 07/18/2002 | US20020094340 Chlamydia antigens and corresponding dna thereof |
| 07/18/2002 | US20020094338 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 07/18/2002 | US20020094337 Prevention of recurrent viral disease |
| 07/18/2002 | US20020094336 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 07/18/2002 | US20020094335 Treating amyloid-related disease in subject by administering antigenic amount of all-D peptide, wherein peptide elicits production of antibodies against peptide and induces an immune response |
| 07/18/2002 | US20020094333 Administration of substance which induces active pathogen replication in cell latently infected with HIV and anti-pathogen drug |
| 07/18/2002 | US20020094323 Administration of reactive oxygen species inhibitor or scavenger and at least one monocyte maturation-promoting agent |
| 07/18/2002 | DE10059631A1 T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie T cell epitopes of the papillomavirus L1 and E7 protein and their use in diagnostics and therapy |
| 07/18/2002 | CA2435874A1 Systems for expression of heterologous proteins in m. capsulatus |
| 07/18/2002 | CA2434793A1 Ancillary composition for the preparation of committed mature dendritic cells |
| 07/18/2002 | CA2434567A1 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | CA2434399A1 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | CA2434042A1 Asip-related proteins |
| 07/18/2002 | CA2433742A1 Proteins and nucleic acids encoding same |
| 07/18/2002 | CA2433740A1 Human glioma antigen and process for preparing the same |
| 07/18/2002 | CA2433689A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | CA2433687A1 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | CA2432883A1 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | CA2429946A1 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | CA2427840A1 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | CA2426588A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | CA2400643A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/17/2002 | EP1222929A2 Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome |
| 07/17/2002 | EP1222928A2 Pharmaceutical compositions for treating or preventing cancer, especially melanoma |
| 07/17/2002 | EP1222927A2 Pharmaceutical compositions having appetite suppressant activity |
| 07/17/2002 | EP1222313A2 Genes associated with obesity and methods for using the same |
| 07/17/2002 | EP1222300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 07/17/2002 | EP1222289A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 07/17/2002 | EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 07/17/2002 | EP1222283A1 DNA IMMUNIZATION AGAINST i CHLAMYDIA /i INFECTION |
| 07/17/2002 | EP1222281A2 Immunoligically significant herpes simplex virus antigens |
| 07/17/2002 | EP1222280A2 Apoptosis inducing proteinaceous substance |
| 07/17/2002 | EP1222279A2 Growth factor polypeptides and nucleic acids encoding same |
| 07/17/2002 | EP1222277A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222274A2 Mage-a12 antigenic peptides and uses thereof |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222272A2 Polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222267A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222266A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 07/17/2002 | EP1222264A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 07/17/2002 | EP1222255A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 07/17/2002 | EP1222254A1 Porcine endogenous retrovirus (poerv) expressed in guinea pig and corresponding animal models |
| 07/17/2002 | EP1222252A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 07/17/2002 | EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/17/2002 | EP1222211A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222202A2 Ab5 toxin b subunit mutants with altered chemical conjug ation characteristics |
| 07/17/2002 | EP1222200A1 Vaccine |
| 07/17/2002 | EP1222198A2 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses |
| 07/17/2002 | EP1221973A1 CD40 antagonist for treating psoriasis |
| 07/17/2002 | EP1221972A1 Plant lectins as mucosal adjuvants |
| 07/17/2002 | EP1221971A2 Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 07/17/2002 | EP1221970A2 Compositions and methods for stimulating an immune response against infectious agents |
| 07/17/2002 | EP1221969A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 07/17/2002 | EP1221968A2 Method of obtaining cellular immune responses from proteins |
| 07/17/2002 | EP1221967A1 Highly efficient dendritic cell-targeted dna-vaccination |
| 07/17/2002 | EP1221965A1 Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 07/17/2002 | EP1221961A1 Induction of a strong immune response to a self-tumor associated antigen |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221937A2 Hybrid matrices and hybrid matrix mixtures |
| 07/17/2002 | EP0895538B1 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
| 07/17/2002 | EP0876398B1 Induction of immune response against desired determinants |
| 07/17/2002 | EP0815450B1 Compounds and methods for the dectection of t. cruzi infection |
| 07/17/2002 | EP0804219B1 Inhibin compositions and methods of use thereof |
| 07/17/2002 | EP0511306B1 Tumor killing effects of enterotoxins and related compounds |
| 07/17/2002 | CN1359370A Esters of L-carnitine or alkanoyl L-carnitines |
| 07/17/2002 | CN1359302A Remedies for immunoogical diseases |
| 07/17/2002 | CN1359301A Prevention and treatment of amyloidogenic disease |
| 07/17/2002 | CN1358862A Pylorus Helicobacterium vac A-B gene expression engineering bacterium construction and its products preparation method |
| 07/17/2002 | CN1358860A Pylorus Helicobacterium fcag A gene expression engineering bacterium construction and its products preparation method |
| 07/17/2002 | CN1087777C Human embryonic Iung fibroblast diploid cell strain suitable for production of virus and process for production of varicella zoster virus using same |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420540 Toxoplasma gondii antigens |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420523 Polypeptide expressed by an insect cell with baculovirus vector |